IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid-Reference-Cited by-同舟云学术

IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid

Published:2019-01 Issue: Volume:96 Page:104-112
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Chakievska Lenche,Holtsche Maike M.,Künstner Axel^ORCID,Goletz Stephanie,Petersen Britt-Sabina,Thaci Diamant,Ibrahim Saleh M.,Ludwig Ralf J.,Franke Andre,Sadik Christian D.,Zillikens Detlef,Hölscher Christoph,Busch Hauke^ORCID,Schmidt Enno

Funder

Deutsche Forschungsgemeinschaft

Excellence Cluster Inflammation at Interfaces

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Pemphigoid diseases;Schmidt;Lancet,2013

2. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice;Fairley;J. Invest. Dermatol.,2007

3. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180;Liu;J. Clin. Invest.,1993

4. Humanization of autoantigen;Nishie;Nat. Med.,2007

5. Fcgamma receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid;Schulze;Am. J. Pathol.,2014

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Bullous pemphigoid combined with Sjögren’s syndrome complicated by central nervous system infection;Frontiers in Immunology;2024-09-10

2. Anti-IL-17 monoclonal antibodies and bullous pemphigoid: treatment or causal agents? A case series and review of the literature;Drugs in Context;2024-07-30

3. Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid;Journal of Clinical Apheresis;2024-06

4. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita;Frontiers in Immunology;2024-05-10

5. Erfolgreiche Behandlung eines Anti‐P200‐Pemphigoids in Verbindung mit Plaque‐Psoriasis mit Guselkumab;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-05